Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector - PubMed (original) (raw)

Affiliations

PMID: 7719929

Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector

J Hersh et al. Gene Ther. 1995 Mar.

Abstract

To regulate gene expression following adenovirus-mediated gene transfer, a strategy was devised utilizing co-infection with two separate adenovirus vectors designed such that the product of one vector modulated the promoter of the second vector. To evaluate this strategy, AdEGR1.TNF, an adenovirus expressing tumor necrosis factor-alpha (TNF) under the control of the early growth response 1 (EGR1) promoter, was used to regulate a transcription unit in AdIL8.beta gal, an adenovirus vector in which the TNF sensitive interleukin-8 (IL-8) promoter drives the expression of beta-galactosidase (beta-gal). Following infection of HS24 cells with AdIL8.beta gal, addition of TNF to the culture induced the expression of beta-gal. Infection of HS24 cells with AdEGR1.TNF resulted in a dose-dependent secretion of TNF. Little beta-gal was produced following co-infection of the cells with the control vector AdCMV.Null (expressing no specific gene) and AdIL8.beta gal. In contrast, co-infection with AdIL8.beta gal and AdEGR1.TNF demonstrated, for a given dose of AdIL8.beta gal, increasing amounts of beta-gal expression dependent on the dose of AdEGR1.TNF. This model suggests control of gene expression in adenovirus-mediated gene transfer can be regulated by utilizing a promoter-gene expression cassette in one vector that modulates the expression of a promoter-gene expression cassette in a second vector.

PubMed Disclaimer

Cited by

Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa.
Tertilt C, Joh J, Krause A, Chou P, Schneeweiss K, Crystal RG, Worgall S. Tertilt C, et al. Infect Immun. 2009 Jul;77(7):3044-55. doi: 10.1128/IAI.00927-08. Epub 2009 Apr 13. Infect Immun. 2009. PMID: 19364838 Free PMC article.
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG. Hashimoto M, et al. Infect Immun. 2005 Oct;73(10):6885-91. doi: 10.1128/IAI.73.10.6885-6891.2005. Infect Immun. 2005. PMID: 16177368 Free PMC article.
Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
Worgall S, Busch A, Rivara M, Bonnyay D, Leopold PL, Merritt R, Hackett NR, Rovelink PW, Bruder JT, Wickham TJ, Kovesdi I, Crystal RG. Worgall S, et al. J Virol. 2004 Mar;78(5):2572-80. doi: 10.1128/jvi.78.5.2572-2580.2004. J Virol. 2004. PMID: 14963160 Free PMC article.
Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity.
Kikuchi T, Crystal RG. Kikuchi T, et al. J Clin Invest. 2001 Sep;108(6):917-27. doi: 10.1172/JCI11564. J Clin Invest. 2001. PMID: 11560961 Free PMC article.
Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.
Kaner RJ, Santiago F, Rahaghi F, Michaels E, Moore JP, Crystal RG. Kaner RJ, et al. Am J Respir Cell Mol Biol. 2010 Aug;43(2):234-42. doi: 10.1165/rcmb.2008-0063OC. Epub 2009 Oct 5. Am J Respir Cell Mol Biol. 2010. PMID: 19805482 Free PMC article.

Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector - PubMed (original) (raw)